How Mount Sinai Medical Center Plans To Utilize AI For Treating Complex Aortic Conditions

By Annie Baker • Feb 13, 2024

Mount Sinai Medical Center announced it is now implementing unique AI software to support treating patients with complex aortic diseases. And as part of a collaboration between Cydar Medical and Medtronic, this software employs state-of-the-art minimally invasive endovascular technology surgeons use at Mount Sinai’s Aortic Center. The medical center is the first and only institution to use this technology in all of Eastern Florida. This product integrates Cydar Maps software with Medtronic services and case support to improve patient care and efficiency with AI-based solutions in a clinical environment.

Cydar’s platform generates a 3D map of the patient’s vascular system and supports and integrates preoperative planning, intraoperative guidance, and postoperative reviews of endovascular surgery. And the platform utilizes AI to update the map throughout the patient’s journey, guaranteeing surgeries are completed with great precision and success. The benefits include significantly decreased radiation exposure, simplified workflows, and increased clinician confidence.

UK-based Cydar developed a mapping platform to transform how information is shared with clinicians in image-guided minimally invasive surgery. And The company designed it to simplify complexities within operating theaters across the globe.

Mount Sinai’s Aortic Center utilizes a collaborative approach between cardiac surgeons, vascular surgeons, cardiologists, and geneticists by coming together to address complex disease processes that otherwise would be very difficult to manage individually. And this multidisciplinary approach allows for custom-made solutions to a variety of unique aortic and endovascular conditions.

KEY QUOTES:

“The thing we are most excited about in the Aortic Center is our incorporation of an AI image-based guidance program that allows us to decrease radiation use on patients and decrease contrast or dye usage, which decreases the risk of problems with kidney function after these procedures, and allows us to perform these procedures in a more expedient manner. It’s very exciting to be at the forefront of what’s considered the future of aortic surgery.”

  • Micheal Ayad, the Co-Director of the Aortic Center

“When you have a collaboration of different specialists, you are not getting a one-size-fits-all therapy but rather a custom made approach. If we’ve learned anything over the past 20 to 30 years, it’s that not all patients’ diseases are the same. Each patient has a specific kind of aneurysm or a specific kind of disease, so a tailored approach provides a better outcome and a more durable outcome.”

  • Ayad

“We are thrilled a medical center as renowned and respected as Mount Sinai has implemented our product into their clinical work. The goal is to provide their surgeons with a more predictable and efficient way to perform minimally invasive, image-guided procedures, leading to optimal results for their patients.”

  • Paul Mussenden, the CEO at Cydar Medical